Suppr超能文献

镰状细胞病:对胎儿血红蛋白水平在血管闭塞性危机发生频率中作用的重新评估。

Sickle Cell Disease: Reappraisal of the Role of Foetal Haemoglobin Levels in the Frequency of Vaso-Occlusive Crisis.

作者信息

Antwi-Boasiako C, Frimpong E, Ababio G K, Dzudzor B, Ekem I, Gyan B, Sodzi-Tettey N A, Antwi D A

机构信息

Department of Physiology, University of Ghana Medical School, P. O. Box 4236, Accra, Ghana.

Department of Medical Biochemistry, University of Ghana Medical School, P. O. Box 4236, Accra, Ghana.

出版信息

Ghana Med J. 2015 Jun;49(2):102-6. doi: 10.4314/gmj.v49i2.7.

Abstract

BACKGROUND

Foetal haemoglobin has been implicated in the modulation of sickle cell crisis. Its level is generally inversely proportional to the severity of sickle cell disease (SCD) for a given sickle cell phenotypes. The main aim of therapy for vaso-occlusive crisis (VOC), which is the hallmark of SCD, is to reduce the chances of sickling through the prevention of polymerization of HbS. One way of preventing this polymerization is by increasing foetal haemoglobin levels.

OBJECTIVES

To determine the relationship between HbF levels and the frequency of crisis in SCD patients in Ghana.

METHOD

A longitudinal retrospective survey covering a period of 30 months was carried out on adult SCD patients at the Sickle Cell Clinic of the Korle-Bu Teaching Hospital.

RESULTS

Eighty-three adults aged 15 to 65 years made up of 40 males and 43 femalea were studied. Analysis of variance (ANOVA) gave significant results in Hb and HbF levels. Higher HbF levels were positively related to less frequent crisis and were significantly high in SCD patients than in controls. HbF effects on the clinical manifestations on SCD were variable.

CONCLUSION

Threshold values of HbF play a role in reducing the frequency of vaso-occlusive crisis in SCD patients and this finding contributes to the body of available literature on SCD severity. However our work does not give the apparent threshold level of helpful HBF Level in SCD.

摘要

背景

胎儿血红蛋白与镰状细胞危象的调节有关。对于给定的镰状细胞表型,其水平通常与镰状细胞病(SCD)的严重程度成反比。血管闭塞性危象(VOC)是SCD的标志,其治疗的主要目标是通过防止HbS聚合来降低镰状化的几率。防止这种聚合的一种方法是提高胎儿血红蛋白水平。

目的

确定加纳SCD患者的HbF水平与危象发生频率之间的关系。

方法

对Korle-Bu教学医院镰状细胞诊所的成年SCD患者进行了一项为期30个月的纵向回顾性调查。

结果

研究了83名年龄在15至65岁之间的成年人,其中男性40名,女性43名。方差分析(ANOVA)在Hb和HbF水平上得出了显著结果。较高的HbF水平与较低的危象发生频率呈正相关,且在SCD患者中显著高于对照组。HbF对SCD临床表现的影响各不相同。

结论

HbF的阈值在降低SCD患者血管闭塞性危象的发生频率中起作用,这一发现为有关SCD严重程度的现有文献增添了内容。然而,我们的研究并未给出SCD中有益的HbF水平的明显阈值。

相似文献

3
Low nitric oxide level is implicated in sickle cell disease and its complications in Ghana.
Vasc Health Risk Manag. 2018 Sep 6;14:199-204. doi: 10.2147/VHRM.S163228. eCollection 2018.
4
Individual red blood cell fetal hemoglobin quantification allows to determine protective thresholds in sickle cell disease.
Am J Hematol. 2020 Nov;95(11):1235-1245. doi: 10.1002/ajh.25937. Epub 2020 Aug 25.
8
Quantitative analysis of erythrocytes containing fetal hemoglobin (F cells) in children with sickle cell disease.
Am J Hematol. 1997 Jan;54(1):40-6. doi: 10.1002/(sici)1096-8652(199701)54:1<40::aid-ajh6>3.0.co;2-4.
10
Association of fetal hemoglobin level with frequency of acute pain episodes in sickle cell disease (HbS-only phenotype) patients.
Blood Cells Mol Dis. 2019 Mar;75:30-34. doi: 10.1016/j.bcmd.2018.12.003. Epub 2018 Dec 20.

引用本文的文献

3
Sickle Cell Disease Update: New Treatments and Challenging Nutritional Interventions.
Nutrients. 2024 Jan 15;16(2):258. doi: 10.3390/nu16020258.
4
Sickle cell disease is a global prototype for integrative research and healthcare.
Adv Genet (Hoboken). 2021 Feb 25;2(1):e10037. doi: 10.1002/ggn2.10037. eCollection 2021 Mar.
7
Renal abnormalities among children with sickle cell conditions in highly resource-limited setting in Ghana.
PLoS One. 2019 Nov 19;14(11):e0225310. doi: 10.1371/journal.pone.0225310. eCollection 2019.
8
Hematological parameters in Ghanaian sickle cell disease patients.
J Blood Med. 2018 Oct 31;9:203-209. doi: 10.2147/JBM.S169872. eCollection 2018.
10
Low nitric oxide level is implicated in sickle cell disease and its complications in Ghana.
Vasc Health Risk Manag. 2018 Sep 6;14:199-204. doi: 10.2147/VHRM.S163228. eCollection 2018.

本文引用的文献

1
Fetal hemoglobin in sickle cell anemia.
Blood. 2011 Jul 7;118(1):19-27. doi: 10.1182/blood-2011-03-325258. Epub 2011 Apr 13.
2
A regression-based association test for case-control studies that uses inferred ancestral haplotype similarity.
Ann Hum Genet. 2009 Sep;73(Pt 5):520-6. doi: 10.1111/j.1469-1809.2009.00536.x. Epub 2009 Jul 20.
4
The Inheritance of Sickle Cell Anemia.
Science. 1949 Jul 15;110(2846):64-6. doi: 10.1126/science.110.2846.64.
5
Fetal hemoglobin during infancy and in sickle cell adults.
Afr Health Sci. 2006 Mar;6(1):51-4. doi: 10.5555/afhs.2006.6.1.51.
6
Sickle-cell disease.
Lancet. 2004;364(9442):1343-60. doi: 10.1016/S0140-6736(04)17192-4.
8
Amelioration of sickle cell disease by persistent fetal hemoglobin.
JAMA. 1961 Sep 23;177:867-9. doi: 10.1001/jama.1961.73040380028011b.
10
Beta-globin gene cluster haplotypes and HbF levels are not the only modulators of sickle cell disease in Lebanon.
Eur J Haematol. 2003 Feb;70(2):79-83. doi: 10.1034/j.1600-0609.2003.00016.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验